FTC

Senators Question President’s Pick for OIRA Administrator

Senators Question President’s Pick for OIRA Administrator

Howard Shelanski questioned on delays, retrospective review, and role for cost-benefit analysis.

FTC Report Shows Increase in Pay-for-Delay Drug Settlements

FTC Report Shows Increase in Pay-for-Delay Drug Settlements

Agency report indicates that potentially anti-competitive drug settlements are on the rise.

OMB Releases Draft of Annual Report on Regulation’s Impacts

OMB Releases Draft of Annual Report on Regulation’s Impacts

Major rules, especially EPA’s, potentially create enormous net benefits.

CFPB Possesses Unique Accountability Structure

CFPB Possesses Unique Accountability Structure

Consumer protection agency is sensibly structured to resist the dangers of client politics.

CFPB Reports to Congress on Fair Debt Collection Practices Act

CFPB Reports to Congress on Fair Debt Collection Practices Act

The agency will focus on promoting fairness for both consumers and law-abiding debt collectors.

Happy Birthday, The Regulatory Review!

Happy Birthday, The Regulatory Review!

RegBlog celebrates two years of regulatory news, analysis, and opinion.

Patent Trolls: No Fairytale Ending in Sight?

Patent Trolls: No Fairytale Ending in Sight?

Debate rages on as Congress considers legislation to solve this problem.

Week in Review

Week in Review

FHFA proposes alternative to Fannie and Freddie, TSA to allow pocket knives onto planes, and more.

FTC Staff Report Outlines Best Practices for Mobile App Industry

FTC Staff Report Outlines Best Practices for Mobile App Industry

Agency provides disclosure guidelines to protect consumer privacy.

Week in Review

Week in Review

DOJ reviews gun safety technology, FCC proposes rule to free up government airwaves, and more.

Are Social Media Sites Engaging in Anti-Competitive Conduct?

Are Social Media Sites Engaging in Anti-Competitive Conduct?

A new paper dissects antitrust claims against social media.

A Prescription for the FDA

A Prescription for the FDA

To solve fundamental problems, food and drug safety agency must adapt.